Companies Like Lexeo Therapeutics (NASDAQ:LXEO) Are In A Position To Invest In Growth [Yahoo! Finance]
![Yahoo! Finance](../../../Content/images/providers/Yahoo! Finance.png)
Lexeo Therapeutics, Inc. (LXEO)
Company Research
Source: Yahoo! Finance
For example, although Amazon.com made losses for many years after listing, if you had bought and held the shares since 1999, you would have made a fortune. But while the successes are well known, investors should not ignore the very many unprofitable companies that simply burn through all their cash and collapse. So should Lexeo Therapeutics NASDAQ:LXEO ) shareholders be worried about its cash burn? In this report, we will consider the company's annual negative free cash flow, henceforth referring to it as the 'cash burn'. First, we'll determine its cash runway by comparing its cash burn with its cash reserves. See our latest analysis for Lexeo Therapeutics When Might Lexeo Therapeutics Run Out Of Money? You can calculate a company's cash runway by dividing the amount of cash it has by the rate at which it is spending that cash. When Lexeo Therapeutics last reported its March 2024 balance sheet in May 2024, it had zero debt and cash worth US$195m. Importantly, its cash burn wa
Show less
Read more
Impact Snapshot
Event Time:
LXEO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LXEO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LXEO alerts
High impacting Lexeo Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
LXEO
News
- Lexeo Therapeutics, Inc. (NASDAQ: LXEO) was upgraded by analysts at Baird R W to a "strong-buy" rating.MarketBeat
- Lexeo Therapeutics, Inc. (NASDAQ: LXEO) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $28.00 price target on the stock.MarketBeat
- Lexeo Therapeutics, Inc. (NASDAQ: LXEO) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $22.00 price target on the stock.MarketBeat
- What Makes Lexeo Therapeutics, Inc. (LXEO) a New Buy Stock [Yahoo! Finance]Yahoo! Finance
- Wall Street Analysts Think Lexeo Therapeutics, Inc. (LXEO) Could Surge 57.82%: Read This Before Placing a Bet [Yahoo! Finance]Yahoo! Finance
LXEO
Sec Filings
- 6/14/24 - Form 4
- 6/12/24 - Form 4
- 5/22/24 - Form 3
- LXEO's page on the SEC website